USPTO issued a trademark registration for KEMPHARM (Registration No. TM78910382) covering medical research services under Class 42. The application was originally filed on June 16, 2006 and achieved registered status on March 30, 2026.

This is a routine trademark registration notice that establishes intellectual property rights for the mark holder. Pharmaceutical companies, medical researchers, and healthcare providers should ensure their own trademark usage does not conflict with or infringe this registered mark for medical research services.